EREkaterina Romanova

Ekaterina Romanova

*This is an algorithmically generated author record based on publicly available information.

Ekaterina Romanova has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Intracorporeal ileotransverse anastomosis in laparoscopic right colectomy. Results of randomized clinical trial

    by E. M. Romanova, O. I. Sushkov, E. S. Surovegin, E. M. Shunin, D. V. Aleshin, D. G. Shakhmatov, A. F. Mingazov, S. I. Achkasov

    AIM: to assess the postoperative complications rate in the groups with intra- and extracorporeal ileotransverse anastomosis in laparoscopic right colectomy.PATIENTS AND METHODS: a single-center, randomized, non-inferiority trial was conducted with intention-to-treat data analysis. There were two groups of patients in whom performed laparoscopic right colectomy using a standardized technique. In the main group (n = 39) intracorporeal ileotransverse anastomosis (IA) was formed, in the comparison group — extracorporeal anastomosis (EA) (n = 40).RESULTS: the operation time in the IA group was 192.4 ± 62.3, and in the EA group — 144.1 ± 41.3 minutes (p = 0.0002). The time of anastomosis formation was also significantly different: 53 (35; 71) minutes in intracorporeal and 30 (26; 35) minutes inn extracorporeal methods (p < 0.0001). The morbidity rate was not significantly different (25.6% vs 27.5%; p = 0.95). In the main group it was 25.6%, and in the control group 27.5% (p = 0.95). Postoperative hospital stay in the main group was significantly less — 5 vs 7.3 days in the comparison group (p < 0.001).CONCLUSION: the randomized trial demonstrated that IA is safe and comparable to EA in terms of the morbidity rate, despite its longer operation time. At the same time, in the IA group, patients achieved discharge criteria earlier, which reduced postoperative hospital stay.


  • Laparoscopic right hemicolectomy with intracorporeal ileo-transverse anastomosis (review)

    by E. M. Romanova, Federal State Budgetary Institution «Ryzhikh National Medical Research Center of Coloproctology» of the Ministry of Health of Russia, E. S. Surovegin, D. G. Shakhmatov, O. I. Sushkov

    Colon cancer is one of the most common malignant tumors worldwide. The main treatment for localized colon cancer is surgery. Nowadays laparoscopic colectomies for colon cancer have advantages over open ones, as they provide better short-term results. There has been a continuous improvement in the technique of the operation, and due to the widespread use of laparoscopic stapling and cutting devices, intracorporeal anastomosis is becoming more and more accessible. This article discusses the advantages and disadvantages of various methods for the formation of ileo-transverse anastomosis in laparoscopic right hemicolectomy.

  • Open Access

    Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study

    by Catherine A Shaw, Riinu Pius, Thomas M Drake, Lisa Norman, Adesoji O Ademuyiwa, Adewale O Adisa, Maria Lorena Aguilera, Sara W Al-Saqqa, Ibrahim Al-Slaibi, Aneel Bhangu, et al.


  • Open Access

    Laparoscopic right colectomy with intracorporeal ileotransverse anastomosis (results of the pilot study)

    by E. M. Romanova, O. I. Sushkov, E. S. Surovegin, D. G. Shakhmatov

    AIM: to evaluate the safety of intra- and extracorporeal ileotransverse anastomosis in laparoscopic right hemicolectomy.PATIENTS AND METHODS: a pilot «case-control» study included two groups of patients, who underwent laparoscopic right colectomy according to a standardized technique. An intracorporeal anastomosis (IA) was formed in the main group (n = 20), in the control group — extracorporeal anastomosis (EA) (n = 18).RESULTS: in main group the postoperative complications rate was 20%, in the control group — 28% (p = 0.71). The postoperative hospital stay in the main group was significantly less than in control (5.0 vs 7.3 days) (p < 0.001).CONCLUSION: the postoperative complications rate in both groups was not significant, but postoperative hospital stay was shorter in IA group. A randomized controlled trial is required.


  • Open Access

    Genetic and phenotypic characteristics of 60 Russian families with Lynch syndrome

    by Yu. A. Shelygin, S. I. Achkasov, D. A. Semenov, O. I. Sushkov, D. G. Shakhmatov, E. M. Romanova, V. P. Shubin, A. S. Tsukanov

    AIM: to evaluate the genetic and clinical characteristics of Russian patients with Lynch syndrome.PATIENTS AND METHODS: in the period from 2012 to 2019, patients with suspected Lynch syndrome were studied, according to the selection recommendations (Amsterdam II and original criteria). All patients underwent a microsatellite instability test in the tumor, and if it was detected, for germline mutations in the genes of MMR system. All patients underwent standard clinical procedures (colonoscopy, gastroscopy, CT, MRI, etc.).RESULTS: Lynch syndrome was genetically confirmed in 60 unrelated patients (included 30 women and 30 men, ranging in age from 24 to 68 years). Germline mutations were found in the following genes: MLH1 — 30, MSH2 — 26, MSH6 — 2, PMS1 — 1, PMS2 — 1. For the first time in the world, 12 novel mutations have been described. Clinical features of Russian patients with Lynch syndrome include: the early average age of development of the first cancer — 39.0 years; frequent 45% localization in the left colon; high (55%) incidence of poorly differentiated adenocarcinomas. A total of 234 tumors were diagnosed in Russian patients with Lynch syndrome and their relatives. It is also important to note that the stomach cancer is the third most common cancer after colon cancer.CONCLUSION: Russian patients with Lynch syndrome showed clinical and genetic and features, that distinguish them from European and North American population and should be taken into account when treating.

  • Open Access

    Quality of life after extended lymph node dissection for colon cancer

    by Yu. A. Shelygin, I. I. Muratov, O. I. Sushkov, D. G. Shakhmatov, K. R. Saifutdinova, E. M. Shunin, E. M. Romanova, S. I. Achkasov

    Aim: to evaluate the effect of the lymphadenectomy (LD) level on the quality of life (QoL) in patients who underwent laparoscopic colon resection for colon cancer.Patients and methods: the study included 86 patients who underwent surgery for colon cancer from January 2018 to August 2020. The patients were randomized in 2 groups: the main group — with D3 lymphadenectomy — 41 patients and the control group — with D2 — 45 patients. Two validated QoL questionnaires (QLQ-C30 v. 3.0, QLQ-CR29 v. 2.1) of the European Organization for Research and Treatment of Cancer (EORTC) were applied by the patients on the day before the surgery and on the 30th day after the surgery and were used for the further analysis.Results: there were no significant differences between the groups in gender, age, weight, height, BMI, assessment of functional and physical status according to the ASA and ECOG scales, incidence of comorbidities, tumor site, type and volume surgical of procedures. Regardless of the level of lymphadenectomy, the significant improvement in QoL after surgery was obtained (pQoLD3 = 0.005, pQoLD2 = 0.023) in both groups. The significant increase in the incidence of diarrhea by 2.65 times was detected after laparoscopic right hemicolectomies with extended lymphadenectomy (p = 0.042). Also, there was a significant 2.45 fold increase in the risk of developing erectile dysfunction (ED) after D3 lymphadenectomy in the patients who underwent laparoscopic resections of the left colon in the early postoperative period (p = 0.031).Conclusion: the analysis of physical, social functioning and symptomatic scales has established that in patients who underwent colon resection for cancer of the left colon erectile dysfunction occurred to a greater extent after D3 LD, whereas diarrhea was more likely to develop after resection of the right colon with D3 LD than with D2 LD.


  • Open Access

    Organization of medical care for patients with colorectal cancer during coronavirus-19 pandemic (review)

    by S. V. Chernyshov, E. M. Romanova, M. A. Tarasov, S. A. Frolov, E. G. Rybakov, Yu. E. Vaganov

    The COVID-19 pandemic, with it is rapid increase in new cases and deaths, has caused hospital overload around the world, creating an unprecedented challenge for health systems and requiring the rapid development of reliable and evidence-based guidelines. Moreover, this has led to urgent identification of non-COVID health priorities. The cancer service must be restructured. Diagnosis and treatment for colorectal cancer in the background of the COVID-19 pandemic requires a restrained approach based on the priority of patient care.


  • Open Access

    MESENCHYMAL TUMORS OF THE COLON AND RECTUM: DIAGNOSIS, TREATMENT, PROGNOSIS (case report and review)

    by O. A. Mainovskaya, M. A. Tarasov, E. M. Romanova, S. V. Chernyshov

    Мезенхимальные опухоли толстой кишки встречаются крайне редко и не имеют специфической клинической картины, их диагностика и стадирование вызывает определённые трудности. Различные типы мезенхимальных опухолей отличаются прогнозом и выбором тактики лечения. Это объясняет важность дифференциальной диагностики этих новообразований между собой и опухолями-производными других эмбриональных структур. В статье описан клинический случай редкой мезенхимальной опухоли толстой кишки, а также тактика ведения пациента.


  • Open Access

    X-RAY ANALYSIS OF THE POSITION OF THE RUDIMENTS OF ABNORMALLY LOCATED LOWER THIRD MOLARS DURING THEIR FORMATION AND GROWTH

    by Marina Morozova, Svetlana Dem'YAnenko, Natalia Marchenka, Vyacheslav Kirichenko, Ekaterina Romanova, Andrey Morozov

    Subject. The issues of indications, contraindications and the optimal timing for the removal of abnormally located lower third molars remain relevant in dentistry. Numerous evidence has been accumulated of their negative impact on the formation of the dentofacial system, however, X-ray patterns of patients with this pathology in the process of their formation, development and change in the angle of inclination, as well as the growing problems associated with the growth of these teeth in the dentition and bite have not been studied. The goal is to study the dynamics of the position of the rudiments of the abnormally located lower third molars in the process of their formation and growth and their influence on the state of the dentofacial system as a whole. Methodology. The study involved 28 patients with abnormally located impressive lower third molars, which were divided into 3 groups: in the first (8 people), the second molars were at the teething and growth stage, in the second (12 people) the second molar was in the occlusal plane at the stage closed apex, in the third (8 people) there was a multiple abnormal position of the mesially located teeth from the third molar. All measurements were performed using a virtual measuring device in the image mode of slices with Galileos Viewer software. Results. According to our results, a significant scatter was recorded in the timing of the formation of third molars from the period of mineralization of the crown of the teeth (12―15 years) to the end of growth and root formation (18―23 years). After 23 years, the roots of the abnormally located lower third molars in the patients examined by us had radiological signs of the end of formation (closed apex). Conclusion. Impact lower third molars continue their growth and have a negative effect on the condition of the teeth located mesial. This fact does not depend on concomitant orthodontic pathology, nor on the methods of orthodontic treatment (removable or non-removable equipment).


  • Open Access

    Isolated Myeloid Sarcoma Involving the Breast

    by Larisa Girshova, Ekaterina Romanova, Irina Kholopova, Tatiana Nikulina, Julia Mirolubova, Andrey Zaritskey

    Abstract 4345 Myeloid sarcoma (MS) is an extramedullary tumor composed of immature myeloid cells. Development of myeloid sarcoma may precede or accompany to AML, CML and other myeloproliferative diseases or myelodysplastic syndrome. About 95% of patients with isolated myeloid sarcoma develop AML within 1–48 months. Sites most commonly affected with myeloid sarcoma are bones, lymph nodes, skin and soft tissue. Isolated myeloid sarcoma of the breast is rare. There is no consensus on the choice of the optimal treatment strategy of primary extramedullary MS at the moment. However, there is evidence of the benefit of systemic chemotherapy, despite the localized nature of this disease. The patient is 30 years old female. The tumor of left breast 3.5 * 2.5 cm first time was identified in 07.2011. It was asymptomatic. Histological examination of the tumor revealed myeloid sarcoma (high expression of SD7, CD34, CD38, CD117, TDT, nucleophosmin, BCL-2, the heterogeneous expression of MPO and a low CD5 expression). MRI with contrast revealed 5 lesions of the left breast with different types of accumulation of contrast. According to CT scan of the thorax, abdomen, pelvis and MRI of the brain no other pathologic lesions have been identified. No abnormalities were also found during examination of peripheral blood and bone marrow. No expression of fusion genes, target gene mutations and abnormal expression of WT1 were revealed during molecular genetic examinations. Bone marrow cytogenetics was normal. The standard induction chemotherapy “7+3” regimen was conducted. 80% reduction of the left breast lesions (according to MRI, ultrasound) was achieved after the first treatment course. This course was followed by HDAC (1 cycle) and local radiotherapy (27 Gray) with complete clinical and radiological response according by PET. PET performed after therapy did not reveal metabolically active tissue in the breast. Second HDAC was used as a consolidation. According to the results of the control MRI remains a single fibrotic lesion in the left breast tissue, PET negative. At present, the patient clinically well for three months from the end of the last HiDAC. A complete remission continues for 7 months. We continue our observation In conclusion, myeloid sarcoma can occasionally involve the breast as an isolated mass in patients without a history or subsequent development of AML. Histologically, myeloid sarcoma can mimic a number of other neoplasms, but especially various types of lymphoma and breast carcinoma, and it can be easily misdiagnosed without an immunophenotypic workup. It remains to be determined whether chemoradiotherapy is superior to chemotherapy alone. In our case, we administered AML chemotherapy and incorporated local radiotherapy as well. Response assessment was performed by breast MRI and PET scans. Timely start of therapy and an adequate volume of therapy allow to achieve complete response in patients with myeloid sarcoma.